Taxotere (docetaxel) is a popular chemotherapy drug made and marketed by Sanofi-Aventis. Doctors prescribe the drug to take care of breast cancer cases in the U.S., and each year about 300,000 women are diagnosed as having the disease. To know more about the professional physiomesh lawyers, you can also go through the web.
The drug is also the most prescribed drug in its class. In 2009, Taxotere made over $3 billion for Sanofi before the company lost patent protection. The treatment plan for Taxotere is once every three weeks, unlike paclitaxel — a drug in the same class — which is the week.
So, patients make a vacation to receive treatment less, a basic fact that is attractive to many women. Some doctors prescribe Taxotere with their patients for reasons of convenience, though studies show paclitaxel is just as effective.
But, studies also linked the drug to a disfiguring side-effect: permanent hair loss, called alopecia. In some cases, about 9 percent of breast cancer patients suffered alopecia that lasted for ten years or more, severely decreasing their quality of living, negatively affecting body image and causing distress and depression.
Perhaps you have or someone you care about suffered long lasting hair loss
Why Women File Taxotere Lawsuits
Hair loss during chemotherapy is expected. It really is a common side-effect of fighting cancers. But, women who underwent treatment with Taxotere didn’t prepare themselves for permanent loss of their hair. What angers several women and their own families is that these were never properly warned of the risk so they will make the best choice.
Despite informing other countries, Sanofi didn’t warn women in the U.S. The word “permanent hair loss” or “alopecia” do not come in any information published in the U.S., corresponding to lawsuits.
The permanent loss of hairs is more than cosmetic. For breast cancers survivors, this can be a continuous reminder of their struggle. To them, life won’t be the same. The loss is emotional, financial and physical.
Lawsuits Filed Against Sanofi-Aventis Claim Several Legal Activities Against The Drug Maker, Including:
– Providing the drug without properly testing it.
– Failing to find out whether the drug was safe.
– Selling the drug without disclosing the dangers or risks.
– Failing to properly alert patients and healthcare providers.
– Misleading the public in marketing and advertising.
– Manufacturing a dangerous drug.
– Concealing information from the public.
– Downplaying the problems from the drug.